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ABSTRACT In the beta- and gammaherpesviruses, a specialized complex of viral
transcriptional activators (vTAs) coordinate to direct expression of virus-encoded late
genes, which are critical for viral assembly and whose transcription initiates only af-
ter the onset of viral DNA replication. The vTAs in Kaposi’s sarcoma-associated her-
pesvirus (KSHV) are ORF18, ORF24, ORF30, ORF31, ORF34, and ORF66. While the gen-
eral organization of the vTA complex has been mapped, the individual roles of these
proteins and how they coordinate to activate late gene promoters remain largely
unknown. Here, we performed a comprehensive mutational analysis of the con-
served residues in ORF18, which is a highly interconnected vTA component. Surpris-
ingly, the mutants were largely selective for disrupting the interaction with ORF30
but not the other three ORF18 binding partners. Furthermore, disrupting the ORF18-
ORF30 interaction weakened the vTA complex as a whole, and an ORF18 point mu-
tant that failed to bind ORF30 was unable to complement an ORF18 null virus. Thus,
contacts between individual vTAs are critical as even small disruptions in this com-
plex result in profound defects in KSHV late gene expression.
IMPORTANCE Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiologic agent
of Kaposi’s sarcoma and other B-cell cancers and remains a leading cause of death
in immunocompromised individuals. A key step in the production of infectious viri-
ons is the transcription of viral late genes, which generates capsid and structural
proteins and requires the coordination of six viral proteins that form a complex. The
role of these proteins during transcription complex formation and the importance of
protein-protein interactions are not well understood. Here, we focused on a central
component of the complex, ORF18, and revealed that disruption of its interaction
with even a single component of the complex (ORF30) prevents late gene expres-
sion and completion of the viral lifecycle. These ﬁndings underscore how individual
interactions between the late gene transcription components are critical for both
the stability and function of the complex.
KEYWORDS KSHV, Kaposi’s sarcoma-associated herpesvirus, ORF18, ORF30,
herpesvirus, late gene transcription
Abroadly conserved feature of the life cycle of double-stranded DNA (dsDNA)viruses is that replication of the viral genome licenses transcription of a speciﬁc
class of viral transcripts termed late genes. There is an intuitive logic behind this
coupling as late genes encode proteins that participate in progeny virion assembly and
egress and, thus, are not needed until newly synthesized genomes are ready for
packaging. Additionally, late gene transcription requires ongoing DNA replication, and
in the gammaherpesviruses Kaposi’s sarcoma-associated herpesvirus (KSHV) and
Epstein-Barr virus (EBV), the increase in template abundance appears insufﬁcient to
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explain the robust transcription of late genes whose products are required in large
amounts (1).
While the mechanisms underlying late gene activation can vary across viral families,
in the beta- and gammaherpesviruses, late gene promoters are strikingly minimalistic
and primarily consist of a modiﬁed TATA box (TATT) and 10 to 15 bp of variable
ﬂanking sequence (2–5). Despite this sequence simplicity, their transcription requires a
dedicated set of at least six conserved viral transcriptional activators (vTAs) whose
precise roles are only beginning to be uncovered. In KSHV, the vTAs are encoded by
open reading frames (ORFs) 18, 24, 30, 31, 34, and 66 (6–15). The best-characterized of
the vTAs is a viral TATA-binding protein (TBP) mimic, encoded by ORF24 in KSHV, which
binds both the late gene promoter and RNA polymerase II (Pol II) (4, 8, 16, 17). Beyond
the viral TBP mimic, the only other vTA with a documented transcription-related
function is pUL79 (homologous to KSHV ORF18) in human cytomegalovirus (HCMV),
which promotes transcription elongation at late times of infection (18). Roles for the
remaining vTAs remain largely elusive although the KSHV ORF34 protein and its murine
cytomegalovirus (MCMV) homolog pM95 may function as hub proteins as they interact
with numerous other vTAs (7, 9, 19). In addition to the six conserved vTAs, in EBV the
kinase activity of BGLF4 (homologous to KSHV ORF36) also contributes to the expres-
sion of late genes (20, 21).
Studies in both beta- and gammaherpesviruses indicate that the vTAs form a
complex, the general organization of which has been mapped in MCMV and KSHV (7,
9, 10, 19) (Fig. 1A). Notably, several recent reports demonstrate that speciﬁc interactions
between the vTAs are critical for late gene transcription. In MCMV, mutation of
conserved residues in pM91 (homologous to KSHV ORF30) that disrupt its interaction
with pM79 (homologous to KSHV ORF18) renders the virus unable to transcribe late
genes (19). Similarly, the interaction between KSHV ORFs 24 and 34 can be abrogated
by a single amino acid mutation in ORF24 which prevents late gene transcription (9).
Further delineating these contacts should provide foundational information relevant to
understanding vTA complex function.
The precise role of KSHV ORF18 in late gene transcription remains unknown;
however, it is predicted to interact with four of the ﬁve other vTAs (ORFs 30, 31, 34, and
66), suggesting that, like ORF34, it may play a central role in vTA complex organization
(7, 9). Here, we performed an interaction screen of mutants of ORF18 to comprehen-
sively evaluate the roles of its conserved residues in mediating pairwise vTA binding.
We reveal that ORF30 is particularly sensitive to mutation in ORF18, enabling isolation
of mutants that selectively abrogate this interaction while retaining the contacts
between ORF18 and the other vTAs. Disrupting the ORF18-ORF30 interaction not only
prevents KSHV late gene transcription as measured by K8.1 expression but also appears
to weaken assembly of the remaining vTA complex. These ﬁndings underscore the key
role that ORF18 plays in late gene transcription and suggest that disrupting just one of
its interactions has a destabilizing effect on the vTA complex as a whole.
(This article was submitted to an online preprint archive [22]).
RESULTS
ORF18 interacts with ORF30, ORF31, ORF34, and ORF66. Previous work using a
split luciferase-based interaction screen suggested that ORF18 is highly interconnected
with other viral late gene activators as it interacted with the majority of the proteins in
the viral transcription preinitiation complex (vPIC) (9). To independently conﬁrm the
binding of ORF18 to ORFs 30, 31, 34, and 66 in the absence of other viral factors, we
assessed its ability to coimmunoprecipitate (co-IP) with each of these vTAs in trans-
fected HEK293T cells. Consistent with the screening data, ORF18 carrying three copies
of a FLAG tag (ORF18-3FLAG) interacted robustly with C-terminal 2Strep-tagged
versions of ORF30, ORF31, and ORF66 (Fig. 1B to D). Although ORF18-3FLAG did not
interact with ORF34 tagged on its C terminus, the interaction was recovered upon
moving the 2Strep tag to the N terminus of ORF34 (Fig. 1E). Furthermore, we
consistently observed that the expression of ORF30 was higher when it was coex-
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pressed with ORF18 than when it was transfected with a vector control, suggesting that
ORF18 may stabilize ORF30 (Fig. 1B). To determine whether ORF18 had a stabilizing
effect on ORF30, the half-life of ORF30 was measured in both the presence and absence
of ORF18. As can be seen in Fig. 1F, stability of ORF30 increased signiﬁcantly when it
was coexpressed with ORF18.
FIG 1 ORF18 interacts with ORFs 30, 31, 34, and 66. (A) Diagram of vTA interactions in KSHV. (Republished from reference 9.) (B to E) HEK293T
cells were transfected with the indicated vTA plasmids and then subjected to co-IP using anti-FLAG beads followed by Western blot analysis with
the indicated antibody to detect ORF18 and either ORF30 (B), ORF31 (C), ORF66 (D), or ORF34 (E). Input represents 2.5% of the lysate used for
co-IP. Vinculin served as a loading control. (F) HEK293T cells were transfected with the indicated vTA plasmids. At 24 h posttransfection,
cycloheximide (CHX) was added to a ﬁnal concentration of 100 g/ml, and samples were collected at the indicated time points after the addition
of cycloheximide. Whole-cell lysate (25 g) was resolved using SDS-PAGE, followed by Western blotting with the indicated antibodies. Vinculin
served as a loading control. Rb, rabbit; Ms, mouse.
Late Gene Expression Requires ORF18-ORF30 Interaction Journal of Virology
January 2019 Volume 93 Issue 1 e01488-18 jvi.asm.org 3
 o
n
 June 3, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
An interaction screen of ORF18 mutants reveals the role of conserved residues
in interactions with the other vTAs. To evaluate the importance of the interaction
between ORF18 and its individual vTA contacts, we aimed to identify point mutations
that disrupted binding to individual vTAs but did not destroy the integrity of the
complex. Since the late gene vTA complex is conserved across the beta- and gamma-
herpesviruses, we reasoned that the individual points of contact might depend on
conserved amino acid residues. We performed a multiple sequence alignment between
KSHV ORF18 and its homologs in ﬁve other beta- and gammaherpesviruses (MHV68
ORF18, HCMV pUL79, MCMV pM79, EBV BVLF1, and bovine herpesvirus [BHV] ORF18)
using MUSCLE (23). The sequence alignment revealed 25 single conserved residues,
including six pairs of adjacent conserved residues, which are depicted in Fig. 2A, which
shows a schematic of the primary structure of ORF18 and the positions of conserved
residues. We mutated each of the 25 conserved residues to alanines in ORF18-3FLAG
and made double alanine mutations in the six cases of adjacent conserved residues
(Fig. 2A). Each of these 31 mutants was screened individually for the ability to interact
with ORFs 30, 31, and 66 by co-IP followed by Western blotting (data not shown). To
FIG 2 ORF18 mutant screen for interactions with ORFs 30, 31, and 66. (A) Diagram depicting the conserved residues in
KSHV ORF18 in a MUSCLE alignment with MHV68 ORF18, EBV BVLF1, HCMV pUL79, MCMV pM79, and BHV4 ORF18. Red
denotes amino acids (aa) found to have interactions at 10% of the WT level with any of the vTAs. (B) Heat map of the
co-IP efﬁciency of each ORF18 mutant against ORFs 30, 31, and 66.
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account for differences in expression levels between the ORF18 mutants, we calculated
the co-IP efﬁciency of each of the mutants, as described in Materials and Methods.
These data were used to generate a heat map, which displays the pairwise interaction
efﬁciencies on a color scale where lighter blocks represent reduced binding and darker
blocks represent increased binding relative to binding of the wild type (WT) ORF (Fig.
2B). Overall, the data revealed that ORF30 was the most sensitive to mutations in
ORF18, as 24 out of the 31 mutants displayed reduced or no binding. ORF31 showed
variable sensitivity to ORF18 mutation (with some mutants even increasing the inter-
action efﬁciency), while the ORF66-ORF18 interaction was relatively refractory to the
ORF18 point mutations (Fig. 2B).
We focused on the six ORF18 mutants that exhibited 10% co-IP efﬁciency, relative
to the WT level, with any vTA in our initial screen (L29A, E36A, L151A, W170A, and
double mutants E36A_L37A and W170A_G171A) (highlighted in red in Fig. 2A). These
were rescreened three to four times independently in co-IP assays with vTA component
ORFs 30, 31, 34, and 66, and the co-IP efﬁciencies were calculated as described in
Materials and Methods and then plotted relative to values obtained for WT ORF18 (Fig.
3A to D). All six of these ORF18 mutants had severe defects in their abilities to co-IP
ORF30, but none were consistently different from the WT ORF18 for interaction with
ORFs 31, 34, and 66 (Fig. 3B to D). Among the six mutants, ORF18E36A_L37A and
ORF18W170A_G171A showed no detectable binding to ORF30, with ORF18E36A_L37A re-
taining nearly WT levels of interaction with the remaining vTAs.
ORF18 point mutants that weaken the interaction between ORF18 and ORF30
have a reduced capacity to activate the K8.1 late gene promoter. A reporter assay
has been developed in which the coexpression of the six individual vTAs can speciﬁcally
FIG 3 Six ORF18 mutants are consistently defective for interaction with ORF30. (A to D) HEK293T cells
were transfected with the indicated vTA plasmids and then subjected to co-IP using anti-FLAG beads,
followed by Western blot analysis to detect the ability of the WT or mutant ORF18 to interact with ORF30
(A), ORF31 (B), ORF34 (C), and ORF66 (D). The co-IP efﬁciencies were calculated as described in the text
for 3 to 4 independent experimental replicates and plotted as bar graphs. In panel A, the dotted line
represents y 0.1, and in panels B to D, the dotted line represents y 1.0.
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activate a KSHV (or EBV) late gene promoter in transfected HEK293T cells (9, 10). We
used this assay as an initial proxy for the ability of the six ORF18 mutants described
above to activate late gene transcription. HEK293T cells were cotransfected with each
of the vTAs, including either the WT or mutant ORF18, and ﬁreﬂy luciferase reporter
plasmids driven by either the late K8.1 promoter or, as a control, the early ORF57
promoter (Fig. 4A). A plasmid containing constitutively expressed Renilla luciferase was
cotransfected with each sample to normalize for transfection efﬁciency. As expected,
inclusion of WT ORF18 with the remaining vTA complex resulted in speciﬁc activation
of the K8.1 late promoter but not of the early ORF57 promoter (Fig. 4B). ORF18 mutants
L29A, E36A, and L151A modestly reduced activation of the late promoter, whereas
more signiﬁcant defects were observed with mutants W170A, E36A_L37A, and
W170A_G171A (Fig. 4B). Although ORF18W170A_G171A had the most pronounced tran-
scriptional defect, this mutant showed somewhat more variability than ORF18E36A_L37A
in its interactions with the other vTA components (Fig. 3 and 4). Thus, we considered
ORF18E36A_L37A to be the top candidate for selectively analyzing the importance of the
ORF18-ORF30 interaction for KSHV late gene transcription.
The interaction between ORF18 and ORF30 affects assembly of the vTA com-
plex. The transcriptional defect of the ORF18E36A_L37A mutant in the reporter assay
could be due to a defect in assembly of the complex or due to defects in downstream
events. To distinguish between these possibilities, WT or mutant ORF18-3FLAG was
cotransfected into HEK293T cells with each of the other Strep-tagged vTAs. We then
FIG 4 Impairing the interaction between ORF18 and ORF30 reduces activation of the late K8.1 promoter. (A)
Diagram depicting the vector combinations that were transfected for the late gene reporter assay. TK, thymidine
kinase; Pr, promoter. (B) HEK293T cells were transfected with the vTA plasmids, including the WT or mutant (Mut)
ORF18, the K8.1 or ORF57 promoter reporter plasmid, and the pRL-TK Renilla plasmid as a transfection control. At
24 h posttransfection the lysates were harvested, and luciferase activity was measured. Data shown are from 3
independent biological replicates, with statistics calculated using an unpaired t test (*, P  0.05; **, P  0.005; ***,
P  0.0007).
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performed an anti-FLAG IP, revealing that puriﬁcation of WT ORF18 led to co-IP of the
complete vTA complex including Pol II, which has been shown to interact with ORF24
in KSHV (8) (Fig. 5). We noted that in this assay ORF18E36A_L37A was more weakly
expressed than WT ORF18, so to compare complex formation with equivalent amounts
of each protein, we titrated down the amount of WT ORF18 to match the levels of
ORF18E36A_L37A. Similar to our observation in a pairwise co-IP (Fig. 1B), the ORF30
protein abundance decreased as the expression of ORF18 was reduced (Fig. 5); how-
ever, the complete vTA complex still copuriﬁed even with reduced levels of WT ORF18
(Fig. 5). Notably, the vTA complex was recovered at lower levels in the presence of
ORF18E36A_L37A. When imaged at a longer exposure, all of the vTAs, with the exception
of ORF30, remained associated with ORF18E36A_L37A (Fig. 5, far right panel). Thus, the
selective loss of the ORF18-ORF30 interaction may reduce the overall stability of the
vTA complex.
The interaction between ORF18 and ORF30 is crucial for expression of the late
gene K8.1. Next, to characterize the effect of ORF18E36A_L37A on the viral replication
cycle, we tested the ability of this mutant to complement the late gene expression
defect of a KSHV mutant lacking ORF18 (18.stop) (6). The renal carcinoma cell line iSLK
harbors the virus (either WT or 18.stop) in a latent state, which can be reactivated upon
expression of the doxycycline-inducible major lytic transactivator RTA and treatment
with sodium butyrate. Using lentiviral transduction, we generated stable, doxycycline-
inducible versions of the 18.stop iSLK cells expressing either ORF18-3FLAG or
ORF18E36A_L37A-3FLAG (18.stop.ORF18WT or 18.stop.ORF18E36A_L37A, respectively).
The cells were assayed 72 h after lytic reactivation for their ability to replicate DNA,
express early and late proteins, and produce progeny virions. Although we observed a
modest decrease of viral DNA replication in the 18.stop cells, as measured by quanti-
tative PCR (qPCR), upon complementation with either WT ORF18 or ORF18E36A_L37A, the
levels of DNA replication were not signiﬁcantly different from those in iSLK cells
infected with WT KSHV (Fig. 6A). Notably, the 18.stop.ORF18E36A_L37A cell line expressed
more ORF18 than the 18.stop.ORF18WT cell line, in contrast to the reduced expression
of the mutant in HEK293T cells (Fig. 6B, compare to levels in Fig. 5). However, while
both reactivated 18.stop.ORF18WT and 18.stop.ORF18E36A_L37A cell lines expressed
FIG 5 Disrupting the interaction between ORF18 and ORF30 weakens the assembly of the vTA complex. HEK293T cells
were transfected with the indicated vTA plasmids and then subjected to co-IP using anti-FLAG beads, followed by Western
blot analysis with the indicated antibody. The boxed lane on the far right represents a longer exposure of the
ORF18E36A_L37A IP. Input represents 2.5% of the lysate used for co-IP. Vinculin was used as a loading control.
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equivalent levels of the ORF59 early protein, only 18.stop.ORF18WT was able to rescue
expression of the model late gene K8.1 (Fig. 6B).
We then evaluated the level of KSHV virion production from the parental WT
KSHV-infected iSLK cells, as well as from the 18.stop, 18.stop.ORF18WT, and
FIG 6 Characterizing the effect of the E36A_L37A ORF18 mutation on the virus. (A) iSLK cells latently
infected with WT KSHV, 18.Stop KSHV, or 18.Stop complemented with ORF18WT or ORF18E36A_L37A were
induced to enter the lytic cycle with 1 g/ml doxycycline and 1 mM sodium butyrate. At 72 h postin-
duction, DNA was isolated, and viral DNA fold replication was measured by qPCR before and after
induction of the lytic cycle. Data shown are from 5 independent biological replicates. (B) Western blots
of the expression of the early protein ORF59, the late protein K8.1, ORF18WT, and ORF18E36A_L37A in the
indicated cell lines induced as described for panel A. GAPDH was used as a loading control. (C) HEK293T
target cells were spinfected with ﬁltered supernatant from induced cells. Progeny virion production was
measured 24 h after supernatant transfer by ﬂow cytometry of GFP-positive (GFP) target cells. Data
shown are from 3 independent biological replicates with statistics calculated using an unpaired t test
(****, P  0.0001).
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18.stop.ORF18E36A_L37A cell lines, using a supernatant transfer assay. KSHV produced
from iSLK cells contains a constitutively expressed green ﬂuorescent protein (GFP),
enabling quantitation of infected recipient cells by ﬂow cytometry (24). Consistent with
a late gene expression defect, neither the 18.stop nor the 18.stop.ORF18E36A_L37A
cell line was able to produce progeny virions, whereas virion production in the
18.stop.ORF18WT cells was indistinguishable from that in the WT KSHV-infected iSLK
cells (Fig. 6C). Collectively, these data demonstrate that the speciﬁc interaction between
ORF18 and ORF30 is essential for K8.1 late gene expression and virion production
during KSHV infection.
The analogous mutation in HCMV pUL79 disrupts its interaction with pUL91. As
shown in Fig. 7A, the E36_L37 residues are conserved across the beta- and gamma-
herpesvirus ORF18 homologs. To determine whether these amino acids are similarly
important in a betaherpesvirus, we engineered the corresponding double mutation in
HCMV pUL79 (pUL79E48A_L49A-3FLAG). Similar to our observation with KSHV ORF30,
HCMV pUL91 protein expression was signiﬁcantly decreased in the absence of its WT
pUL79 binding partner (Fig. 7B). This is consistent with the idea that pUL79 binding
stabilizes pUL91. Furthermore, in co-IP assays we detected a robust interaction between
pUL79 and pUL91, which was impaired in the presence of pUL79E48A_L49A, even when
we accounted for the expression level differences of pUL91 (Fig. 7B). This suggests that
the overall protein-protein interface may be conserved in the analogous ORF18-ORF30
interaction across the beta- and gammaherpesviruses.
DISCUSSION
Elucidating the architecture of the six-member vPIC complex is central to under-
standing the mechanism underlying viral late gene expression in beta- and gamma-
herpesviruses. Although their functions are largely unknown, each of these viral
transcription regulators is essential for late gene promoter activation, and evidence
increasingly suggests that their ability to form a complex is crucial for transcriptional
activity (9, 10, 19). Here, we reveal that selective disruption of an individual protein-
protein contact between KSHV ORF18 and ORF30 within the vPIC is sufﬁcient to
abrogate K8.1 late gene expression and virion production in infected cells, emphasizing
the sensitivity of the complex to organizational perturbation.
We selected ORF18 for mutational screening due to its ability to form pairwise
interactions with the majority of other vPIC components, which suggested that it might
serve as an organizational hub for vPIC assembly, similar to what has been proposed for
ORF34 (7, 9). However, the 31 tested mutants of ORF18 revealed that conserved
residues across the length of the protein are extensively—and largely selectively—
required for ORF30 binding. This is in contrast to the interaction between the vPIC
components ORF24 and ORF34, where the interaction can be localized to a 17-amino-
FIG 7 Mutating E48_L49 in pUL79 disrupts its interaction with pUL91. (A) MUSCLE multiple sequence alignment for HCMV pUL79 and
homologs showing the location of conserved amino acids (in red) that correspond to E36_L37 in KSHV ORF18. (B) HEK293T cells were
transfected with the indicated plasmids and then subjected to co-IP using anti-FLAG beads, followed by Western blot analysis with
the indicated antibody. To normalize for the difference in expression levels of pUL91 under the different transfection conditions, the
co-IP efﬁciency was multiplied by the fold expression of pUL91 in the presence of WT pUL79 versus that with E48A_L49A pUL79. Input
represents 2.5% of lysate used for co-IP. Vinculin was used as a loading control.
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acid stretch of ORF24 (9). The observation that the majority of the point mutations in
ORF18 that disrupt the interaction with ORF30 do not affect its binding to ORFs 31, 34,
and 66 indicates that these mutations do not signiﬁcantly alter the overall folding or
structure of ORF18. In MCMV, the organization of the vTA complex is similar to that of
KSHV, except that pM92 (homologous to KSHV ORF31) interacts with pM87 (homolo-
gous to KSHV ORF24), whereas in KSHV this interaction is bridged through ORF34 (19).
Our data complement recent ﬁndings in MCMV, in which mutations of the ORF30
homolog (pM91) that perturb the interaction with the ORF18 homolog (pM79) similarly
cause a defect in the expression of late genes (19). Thus, mutations that disrupt the
ORF18-ORF30 protein-protein interface in either protein cause the same phenotype.
The ORF18-ORF30 interaction appears sensitive to single amino acid changes in the
protein-protein interface. The ORF18E36A_L37A mutation does not impair binding to its
other vPIC partners in pairwise co-IP experiments, and ORF30 does not engage in
pairwise interactions with vPIC components other than ORF18 (7, 9). It is therefore
notable that the efﬁciency of the vPIC complex assembly is reduced in HEK293T cells in
the presence of the ORF18E36A_L37A mutant, suggesting that the ORF18-ORF30 inter-
action contributes to the stability of the complex as a whole. The interaction between
ORF18 and ORF30 may change the conformation of ORF18, allowing it to interact more
strongly with the other vTAs. Alternatively, the E36A_L37A mutation may contribute to
binding defects between ORF18 and the other vTAs that are not observed with pairwise
interactions but are enhanced in the presence of all the ORF18 binding partners.
We observed that ORF30 protein expression was consistently higher in the presence
of WT ORF18 or ORF18 mutants that retained ORF30 binding, suggesting that ORF18
helps stabilize ORF30. In silico protein stability prediction studies have suggested that
protein stability is in part affected by protein length, where proteins that are less than
100 amino acids tend to be less stable (25, 26). One explanation for the higher
expression of ORF30 in the presence of ORF18 could therefore be that the 77-amino-
acid ORF30 is protected from degradation by ORF18. Another possibility is that ORF18
helps keep ORF30 correctly folded; this has been proposed as a mechanism that
stabilizes proteins which have interaction partners (27). The interaction-induced stabil-
ity of a protein often correlates with the relative concentration of its binding partners
(27), as we observed when we titrated down the amount of ORF18 in the context of the
complete vTA complex. A similar observation has been made between KSHV proteins
ORF36 and ORF45, where ORF36 was dependent on the interaction with ORF45 for
stabilization (28). We did not observe a similar correlation with levels of the other
ORF18-associated vPIC proteins, and, thus, their stability may not require protective
interactions. We also observed a stabilizing effect of pUL79 on pUL91, indicating this
may be a conserved feature of this interaction in other beta- and gammaherpesviruses.
The fact that the late gene expression defect of the ORF18E36A_L37A mutant is
exacerbated in the context of the virus, compared to that in the plasmid promoter
activation assay, likely reﬂects the fact that the plasmid assay measures basal promoter
activation but misses other regulatory components of this cascade. For example, the
origin of lytic replication is required in cis for late gene expression in related gamma-
herpesviruses (3, 29), and the reporter assay does not capture the important contribu-
tion of viral DNA replication toward late gene expression. This may explain why some
mutants that are defective for ORF30 binding (e.g., L29A, E36A, and L151A) retain
partial plasmid promoter activity; perhaps some weak binding between ORF18 and
ORF30 enables basal activation of the promoter in a context where the vPIC compo-
nents are overexpressed. Alternatively, some of the mutations may cause ORF18 to bind
to ORF30 more transiently, but their vPIC interaction becomes stabilized in the pres-
ence of a late gene promoter.
In summary, the absence of K8.1 late gene expression in the KSHV ORF18.stop-
infected cells complemented with ORF18E36A_L37A may derive from a cascade of
phenotypes: the failure to recruit ORF30 to the vPIC, the ensuing reduction in the
efﬁciency of overall vPIC complex assembly, and the reduced stability of ORF30 (if it also
has additional vPIC-independent functions). Ultimately, generating antibodies that
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recognize the endogenous KSHV vPIC components will enable these phenotypes to be
explored further during infection. In addition, information about the three-dimensional
structure of the vPIC would signiﬁcantly enhance our understanding of this unique
transcription complex as it is becoming increasingly clear that even small disruptions to
the complex dramatically impact completion of the viral life cycle.
MATERIALS AND METHODS
Plasmids and plasmid construction. To generate ORF18-3FLAG pCDNA4, ORF18 was subcloned
into the BamHI and NotI sites of pCDNA-3FLAG. The point mutations in ORF18 were generated using
two-primer site-directed mutagenesis with Kapa HiFi polymerase (Roche) with primers 1 to 62 listed in
Table 1. All subsequent plasmids described below were generated using InFusion cloning (Clontech)
unless indicated otherwise. To generate plasmid pLVX-TetOneZeo, Zeocin resistance was PCR ampliﬁed
out of plasmid pLJM1-EGFP-Zeo with primers 63/64 (Table 1) and used to replace the puromycin
resistance in pLVX-TetOne-Puro (Clontech) using the AvrII and MluI restriction sites. To generate
pLVX-TetOneZeo-ORF18WT-3FLAG and pLVX-TetOneZeo-ORF18E36A_L37A-3FLAG, ORF18WT-3FLAG
and ORF18E36_37A-3FLAG were PCR ampliﬁed from each respective pCDNA4 plasmid using primers
71/72 and inserted into the EcoRI and BamHI sites of pLVX-TetOne-Zeo. To generate UL79-3FLAG
pCDNA4 and UL91-2Strep pCDNA4, UL79 was PCR ampliﬁed with primers 67/68 (Table 1), and UL91
was PCR ampliﬁed with primers 69/70 (Table 1) from the HCMV Towne strain, which was kindly provided
by Laurent Coscoy, and cloned into the BamHI and NotI sites of 3FLAG (Cterm) pCDNA4 (where Cterm
indicates a C-terminal tag) or 2Strep (Cterm) pCDNA4. UL79E48A_L49A was generated with two-primer
site-directed mutagenesis using Kapa HiFi polymerase with primers 73/74 (Table 1). To make 2Strep-
ORF34 pCDNA4, ORF34 was PCR ampliﬁed from ORF34-2Strep pCDNA4 with primers 65/66 and cloned
into the NotI and XbaI sites of 2Strep (Nterm) pCDNA4 (where Nterm indicates an N-terminal tag).
Plasmid K8.1 Pr pGL4.16 contains the minimal K8.1 promoter, and ORF57 Pr pGL4.16 contains a minimal
ORF57 early gene promoter; both have been described previously (9). Plasmids ORF18-2Strep pCDNA4,
ORF24-2Strep pCDNA4, ORF30-2Strep pCDNA4, ORF31-2Strep pCDNA4, ORF34-2Strep pCDNA4,
and ORF66-2Strep pCDNA4 have been previously described (8). Plasmid pRL-TK (Promega) was kindly
provided by Russel Vance. Lentiviral packaging plasmids psPAX2 (plasmid number 12260; Addgene) and
pMD2.G (plasmid number 12259; Addgene) were gifts from Didier Trono.
Cells and transfections. HEK293T cells (ATCC CRL-3216) were maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Seradygm). The iSLK renal
carcinoma cell line harboring the KSHV genome on the bacterial artiﬁcial chromosome BAC16 and a
doxycycline-inducible copy of the KSHV lytic transactivator RTA (iSLK-BAC16) have been described
previously (24). iSLK-BAC16-ORF18.stop cells that contain a stop mutation in ORF18 were kindly provided
by Ting-Ting Wu (6). iSLK-BAC16 and iSLK-BAC16-ORF18.stop were maintained in DMEM supple-
mented with 10% FBS, 1 mg/ml hygromycin, and 1 g/ml puromycin (iSLK-BAC16 medium). iSLK-
BAC16-ORF18.stop cells were complemented by lentiviral transduction with ORF18WT-3FLAG or
ORF18E36A_L37A-3FLAG. To generate the lentivirus, HEK293T cells were cotransfected with pLVX-
TetOneZeo-ORF18WT-3FLAG or pLVX-TetOneZeo-ORF18E36A_L37A-3FLAG along with the packaging
plasmids pMD2.G and psPAX2. After 48 h, the supernatant was harvested and syringe ﬁltered through a
0.45-m-pore-size ﬁlter (Millipore). The supernatant was diluted 1:2 with DMEM, and Polybrene was
added to a ﬁnal concentration of 8 g/ml. A total of 1 106 iSLK-BAC16-ORF18.stop freshly trypsinized
cells were spinfected in a six-well plate for 2 h at 500  g. After 24 h the cells were expanded to a 10-cm
tissue culture plate and selected for 2 weeks in iSLK-BAC16 medium supplemented with 325 g/ml
Zeocin (Sigma). For DNA transfections, HEK293T cells were plated and transfected after 24 h at 70%
conﬂuence with PolyJet (SignaGen).
Immunoprecipitation and Western blotting. Cell lysates were prepared 24 h after transfection by
washing and pelleting cells in cold phosphate-buffered saline (PBS), resuspending the pellets in IP lysis
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, and protease inhibitor [Roche]),
and rotating the samples for 30 min at 4°C. Lysates were cleared by centrifugation at 21,000  g for
10 min, and then 1 mg (for pairwise interaction IPs) or 2 mg (for the entire late gene complex IPs) of lysate
was incubated with prewashed M2 anti-FLAG magnetic beads (Sigma) overnight. The beads were
washed three times for 5 min each with IP wash buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA,
0.05% NP-40) and eluted with 2 Laemmli sample buffer (Bio-Rad).
Lysates and elutions were resolved by SDS-PAGE and subjected to Western blotting in TBST
(Tris-buffered saline, 0.2% Tween 20) using the following primary antibodies: Strep-horseradish peroxi-
dase (HRP) (1:2500; Millipore), rabbit anti-FLAG (1:3,000; Sigma), mouse anti-FLAG (1:1,000; Sigma), rabbit
anti-vinculin (1:1,000; Abcam), mouse anti- glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1:
1,000; Abcam), mouse anti-Pol II C-terminal domain (CTD) clone 8WG16 (1:1,000; Abcam), rabbit anti-K8.1
(1:10,000), and rabbit anti-ORF59 (1:10,000). Rabbit anti-ORF59 and anti-K8.1 were produced by the
Pocono Rabbit Farm and Laboratory by immunizing rabbits against MBP-ORF59 or MBP-K8.1 (gifts from
Denise Whitby [30]). Following incubation with primary antibodies, the membranes were washed with
TBST and incubated with the appropriate secondary antibody. The secondary antibodies used were the
following: goat anti-mouse-HRP (1:5,000; Southern Biotech) and goat anti-rabbit-HRP (1:5,000; Southern
Biotech).
The co-IP efﬁciency for the pairwise interactions was quantiﬁed from the Western blot images using
Image Lab software (Bio-Rad). The band intensities for both the Strep-tagged ORF and ORF18WT-3FLAG
or the mutant ORF18 (ORF18Mu-3FLAG) were calculated for the IP lanes of the Western blots. The ratio
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TABLE 1 Primer sequences used in this study
Primer no. Target or purpose Sequence 5=–3= Orientationa
1 ORF18 (L29A) CATGTGGCGCTTTTTGCAAAATAAGAATGCAAATACATTCCACGCCCAAG F
2 ORF18 (L29A) CTTGGGCGTGGAATGTATTTGCATTCTTATTTTGCAAAAAGCGCCACATG R
3 ORF18 (E36A) AATACATTCCACGCCCAAGCGCTGCGTTTTATTCATTTG F
4 ORF18 (E36A) CAAATGAATAAAACGCAGCGCTTGGGCGTGGAATGTATT R
5 ORF18 (L37A) GAACCAAATGAATAAAACGCGCCTCTTGGGCGTGGAATGTAT F
6 ORF18 (L37A) ATACATTCCACGCCCAAGAGGCGCGTTTTATTCATTTGGTTC R
7 ORF18 (N63A) GGGAGGCTACTGCCGCTGCCGGGACCTACG F
8 ORF18 (N63A) CGTAGGTCCCGGCAGCGGCAGTAGCCTCCC R
9 ORF18 (G65A) CTCGTCGTAGGTCGCGGCATTGGCAGT F
10 ORF18 (G65A) ACTGCCAATGCCGCGACCTACGACGAG R
11 ORF18 (L72A) GAACCTTGCGTCCCGCGACCACCTCGTCGT F
12 ORF18 (L72A) ACGACGAGGTGGTCGCGGGACGCAAGGTTC R
13 ORF18 (R74A) CGCAGGAACCTTGGCTCCCAGGACCACC F
14 ORF18 (R74A) GGTGGTCCTGGGAGCCAAGGTTCCTGCG R
15 ORF18 (K75A) GGTCCTGGGACGCGCGGTTCCTGCGGAG F
16 ORF18 (K75A) CTCCGCAGGAACCGCGCGTCCCAGGACC R
17 ORF18 (W81A) TCGTACACGAGCTTCGCCACCTCCGCAGGAAC F
18 ORF18 (W81A) GTTCCTGCGGAGGTGGCGAAGCTCGTGTACGA R
19 ORF18 (Y85A) TCCTCGAGCCCATCGGCCACGAGCTTCCACAC F
20 ORF18 (Y85A) GTGTGGAAGCTCGTGGCCGATGGGCTCGAGGA R
21 ORF18 (L107A) GTTCAAGTGCATCCAGGCGCTGTCCCGGTATGCC F
22 ORF18 (L107A) GGCATACCGGGACAGCGCCTGGATGCACTTGAAC R
23 ORF18 (G130A) GTCGTGGGTGACCGCTAGCCGGTGAAA F
24 ORF18 (G130A) TTTCACCGGCTAGCGGTCACCCACGAC R
25 ORF18 (G145A) CAGATTAAACAAAAAGTTTGCGTCCACCAGGTTTTCCG F
26 ORF18 (G145A) CGGAAAACCTGGTGGACGCAAACTTTTTGTTTAATCTG R
27 ORF18 (N146A) TTCCCAGATTAAACAAAAAGGCTCCGTCCACCAGGTTTTCCG F
28 ORF18 (N146A) CGGAAAACCTGGTGGACGGAGCCTTTTTGTTTAATCTGGGAA R
29 ORF18 (L151A) GAGCACACTTCCCGCATTAAACAAAAAGTTTCCGTCCACC F
30 ORF18 (L151A) GGTGGACGGAAACTTTTTGTTTAATGCGGGAAGTGTGCTC R
31 ORF18 (G152A) TGCAGGGGAGCACACTTGCCAGATTAAACAAAAAG F
32 ORF18 (G152A) CTTTTTGTTTAATCTGGCAAGTGTGCTCCCCTGCA R
33 ORF18 (R158A) CGCAAGGAGCAGCGCGCAGGGGAGCACA F
34 ORF18 (R158A) TGTGCTCCCCTGCGCGCTGCTCCTTGCG R
35 ORF18 (L159A) CGCCGCAAGGAGCGCCCTGCAGGGGAGC F
36 ORF18 (L159A) GCTCCCCTGCAGGGCGCTCCTTGCGGCG R
37 ORF18 (W170A) ATCGCTGCCCGCAAAGGCGAGGCAGTAGCCC F
38 ORF18 (W170A) GGGCTACTGCCTCGCCTTTGCGGGCAGCGAT R
39 ORF18 (G171A) CGTGTTCATCGCTGGCCCAAAAGGCGAGG F
40 ORF18 (G171A) CCTCGCCTTTTGGGCCAGCGATGAACACG R
41 ORF18 (E176A) GCGCACCCAGCGTGCGTGTTCATCGCT F
42 ORF18 (E176A) AGCGATGAACACGCACGCTGGGTGCGC R
43 ORF18 (R180A) CTGGGCGAAGAAGGCCACCCAGCGTTCG F
44 ORF18 (R180A) CGAACGCTGGGTGGCCTTCTTCGCCCAG R
45 ORF18 (L191A) AAGACGCCCGGAGACTATCGCGTAGCAAATGAAAAGCTTC F
46 ORF18 (L191A) GAAGCTTTTCATTTGCTACGCGATAGTCTCCGGGCGTCTT R
47 ORF18 (G214A) CCTCCACCGGAGCGGGATAGCCC F
48 ORF18 (G214A) GGGCTATCCCGCTCCGGTGGAGG R
49 ORF18 (G228A) GCATACGTTCGTATGGCGTACATGGAGCGGA F
50 ORF18 (G228A) TCCGCTCCATGTACGCCATACGAACGTATGC R
51 ORF18 (E36A_L37A) CAGAGAACCAAATGAATAAAACGCGCCGCTTGGGCGTGGAATGTATTTAAAT F
52 ORF18 (E36A_L37A) ATTTAAATACATTCCACGCCCAAGCGGCGCGTTTTATTCATTTGGTTCTCTG R
53 ORF18 (R74A_K75A) CCTCCGCAGGAACCGCGGCTCCCAGGACCACCTCGTC F
54 ORF18 (R74A_K75A) GACGAGGTGGTCCTGGGAGCCGCGGTTCCTGCGGAGG R
55 ORF18 (G145A_N146A) CTTCCCAGATTAAACAAAAAGGCTGCGTCCACCAGGTTTTCCGGGG F
56 ORF18 (G145A_N146A) CCCCGGAAAACCTGGTGGACGCAGCCTTTTTGTTTAATCTGGGAAG R
57 ORF18 (L151A_G152A) AGGGGAGCACACTTGCCGCATTAAACAAAAAGTTTCCGTCCACCA F
58 ORF18 (L151A_G152A) TGGTGGACGGAAACTTTTTGTTTAATGCGGCAAGTGTGCTCCCCT R
59 ORF18 (R158A_L159A) CCGCCGCAAGGAGCGCCGCGCAGGGGAGCACAC F
60 ORF18 (R158A_L159A) GTGTGCTCCCCTGCGCGGCGCTCCTTGCGGCGG R
61 ORF18 (W170A_G171A) GTGTTCATCGCTGGCCGCAAAGGCGAGGCAGTAGCC F
62 ORF18 (W170A_G171A) GGCTACTGCCTCGCCTTTGCGGCCAGCGATGAACAC R
63 pLVX-TetOneZeo TTTTTGGAGGCCTAGGCTTTTGCAAAACGCGACCATGGCCAAGTTGACCAGTGC F
64 pLVX-TetOneZeo ATTGTTCCAGACGCGTTCAGTCCTGCTCCTCGGC R
65 2xStrep-ORF34 pCDNA4 GAGAAGGGGGCGGCCTTTGCTTTGAGCTCGCTCGTGT F
66 2xStrep-ORF34 pCDNA4 AAACGGGCCCTCTAGTTAGAGTTGGTTGAGTCCATTCTCCTTGATC R
67 UL79-3xFLAG pCDNA4 TACCGAGCTCGGATCATGATGGCCCGCGACG F
68 UL79-3xFLAG pCDNA4 CTCCCTCGAGCGGCCCCACGTCGTTAGCCAGCGT R
69 UL91-2xStrep pCDNA4 TACCGAGCTCGGATCATGAACTCGTTGCTGGCGG F
70 UL91-2xStrep pCDNA4 CTCCCTCGAGCGGCCCTGTCACAGGCGCCCGAG R
71 ORF18WT and ORF18E36_L37A pLVX TetOneZeo CCCTCGTAAAGAATTATGCTCGGAAAATACGTGTGTGAGACC F
72 ORF18WT and ORF18E36_L37A pLVX TetOneZeo GAGGTGGTCTGGATCTTAAACGGGCCCCTTGTCGTCG R
73 UL79E48_L49A-3xFLAG pCDNA4 ATGAGGCGTACGATCTTGGCTGCTTCCAAACGCAGCGAGC F
74 UL79E48_L49A-3xFLAG pCDNA4 GCTCGCTGCGTTTGGAAGCAGCCAAGATCGTACGCCTCAT R
(Continued on next page)
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of the band intensity of the Strep-tagged ORF to ORF18Mu-3FLAG was divided by the ratio of the
Strep-tagged ORF to ORF18WT-3FLAG to generate a co-IP efﬁciency for each ORF18Mu relative to the
co-IP efﬁciency of ORF18WT.
ORF30 protein stability. Translation was inhibited 24 h after transfection by the addition of
100 g/ml cycloheximide for 0 to 8 h. Cells were washed once in cold PBS, and cell pellets were frozen
until all samples were collected. The pellets were lysed in IP lysis buffer by rotation for 30 min at 4°C.
Lysates were cleared by centrifugation at 21,000 g for 10 min and then resolved by SDS-PAGE followed
by Western blotting.
Virus characterization. For reactivation studies, 1 106 iSLK cells were plated in 10-cm dishes for
16 h and then induced with 1 g/ml doxycycline and 1 mM sodium butyrate for an additional 72 h. To
determine the DNA fold induction in reactivated cells, the cells were scraped and triturated in the
induced medium, and 200 l of the cell/supernatant suspension was treated overnight with 80 g/ml
proteinase K (Promega) in 1 proteinase K digestion buffer (10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM
EDTA, 0.5% SDS), after which DNA was extracted using a Quick-DNA Miniprep kit (Zymo). Viral DNA fold
induction was quantiﬁed by qPCR using iTaq Universal SYBR Green Supermix (Bio-Rad) on a QuantStu-
dio3 real-time PCR machine with primers 75/76 (Table 1) for the KSHV ORF59 promoter and normalized
to the level of the GAPDH promoter with primers 77/78 (Table 1).
Infectious virion production was determined by supernatant transfer assay. Supernatant from in-
duced iSLK cells was syringe ﬁltered through a 0.45-m-pore-size ﬁlter and diluted 1:2 with DMEM; then
2 ml of the supernatant was spinoculated onto 1 106 freshly trypsinized HEK293T cells for 2 h at 500 
g. After 24 h, the medium was aspirated, and the cells were washed once with cold PBS and cross-linked
in 4% paraformaldehyde (PFA) (Ted Pella) diluted in PBS. The cells were pelleted and resuspended in PBS,
and a minimum of 50,000 cells/sample were analyzed on a BD Accuri 6 ﬂow cytometer. The data were
analyzed using FlowJo (31).
Late gene reporter assay. HEK293T cells were plated in a six-well plate, and each well was
transfected with 900 ng of DNA containing 125 ng each of pcDNA4 ORF18-3FLAG or ORF18Mu-3FLAG,
ORF24-2Strep, ORF30-2Strep, ORF31-2Strep, 2Strep-ORF34, ORF66-2Strep and either K8.1 Pr
pGL4.16 or ORF57 Pr pGL4.16, along with 25 ng of pRL-TK as an internal transfection control. To
determine the basal promoter activity for the K8.1 and ORF57 promoters, HEK293T cells were transfected
with 900 ng of DNA containing 125 ng of K8.1 Pr pGL4.16 or ORF57 Pr pGL4.16 along with 750 ng of
empty pCDNA4 and 25 ng of pRL-TK. After 24 h, the cells were rinsed once with PBS, lysed by rocking
for 15 min at room temperature in 500 l of passive lysis buffer (Promega), and clariﬁed by centrifugation
at 21,000  g for 2 min. Twenty microliters of the clariﬁed lysate was added in triplicate to a white
chimney well microplate (Greiner Bio-One) to measure luminescence on a Tecan M1000 microplate
reader using a Dual-Luciferase Assay kit (Promega). The ﬁreﬂy luminescence was normalized to that of
the internal Renilla luciferase control for each transfection.
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